N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line

Theresa Kissel,Veerle F. A. M. Derksen,Arthur E. H. Bentlage,Carolien Koeleman,Lise Hafkenscheid,Diane van der Woude,Manfred Wuhrer,Gestur Vidarsson,René E. M. Toes

DOI: https://doi.org/10.1038/s41467-023-44468-5

IF: 16.6

2024-01-09

Nature Communications

Abstract:Abstract IgG secreted by B cells carry asparagine N(297)-linked glycans in the fragment crystallizable (Fc) region. Changes in Fc glycosylation are related to health or disease and are functionally relevant, as IgG without Fc glycans cannot bind to Fcɣ receptors or complement factors. However, it is currently unknown whether ɣ-heavy chain (ɣHC) glycans also influence the function of membrane-bound IgG-B-cell receptors (BCR) and thus the outcome of the B-cell immune response. Here, we show in a germinal center (GC)-derived human B-cell line that ɣHC glycans do not affect membrane expression of IgG-BCRs. Furthermore, antigen binding or other BCR-facilitated mechanisms appear unaffected, including BCR downmodulation or BCR-mediated signaling. As expected, secreted IgG lacking Fc glycosylation is unable to carry out effector functions. Together, these observations indicate that IgG-Fc glycosylation serves as a mechanism to control the effector functions of antibodies, but does not regulate the activation of IgG-switched B cells, as its absence had no apparent impact on BCR function.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: Does N - linked Fc glycosylation have an impact on the function of IgG - B - cell receptor (BCR), especially in B - cell - mediated immune responses? Specifically, the researchers wanted to know whether glycosylation on the gamma heavy chain (γHC) would affect the expression of membrane - bound IgG - BCR, antigen - binding ability, BCR - mediated signal transduction, and antigen endocytosis. In addition, they also explored whether secreted IgG could still perform its effector functions, such as binding to Fcγ receptors or activating the complement system, in the absence of γHC glycosylation.

By generating a human B - cell line derived from Burkitt lymphoma (Ramos) that was able to express IgG - BCR with or without γHC glycosylation, the researchers tested the performance of these cell lines under different conditions. The results showed that, regardless of the presence or absence of γHC glycosylation, the surface expression, antigen recognition, signal transduction, and antigen endocytosis of IgG - BCR were not affected. However, when secreted IgG lacked Fc glycosylation, it could not perform effector functions such as binding to Fcγ receptors or activating the classical complement pathway.

In conclusion, this paper reveals that γHC glycosylation is not essential for IgG - BCR function, but is a key factor for secreted IgG to perform its effector functions. This finding helps to better understand the molecular mechanisms in B - cell - mediated immune responses and may have an impact on future immunotherapy strategies.